BIOGEN INC. Other Noncash Income (Expense)
BIOGEN INC. (BIIB) reported Other Noncash Income (Expense) of -$28.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-04-29
- BIOGEN INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$28.00M.
- BIOGEN INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$19.00M.
- BIOGEN INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$33.30M.
- BIOGEN INC. other noncash income (expense) for the quarter ending 2025-06-30 was -$9.30M.
- BIOGEN INC. other noncash income (expense) for fiscal 2025 was -$68.30M.
- BIOGEN INC. other noncash income (expense) for fiscal 2024 was -$159.60M.
- BIOGEN INC. other noncash income (expense) for fiscal 2023 was -$148.20M.
- BIOGEN INC. other noncash income (expense) for fiscal 2022 was -$208.20M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$28.00M 10-Q · filed 2026-04-29 | -$47.00M derived: sum of 2 quarters · filed 2026-04-29 | -$80.30M derived: sum of 3 quarters · filed 2026-04-29 | -$89.60M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$52.30M derived: sum of 2 quarters · filed 2026-02-06 | -$61.60M derived: sum of 3 quarters · filed 2026-02-06 | -$68.30M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | -$33.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$42.60M derived: sum of 2 quarters · filed 2025-10-30 | -$49.30M 10-Q · filed 2025-10-30 | -$113.80M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$16.00M 10-Q · filed 2025-07-31 | -$80.50M derived: sum of 3 quarters · filed 2026-04-29 | -$110.60M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$6.70M 10-Q · filed 2026-04-29 | -$71.20M derived: sum of 2 quarters · filed 2026-04-29 | -$101.30M derived: sum of 3 quarters · filed 2026-04-29 | -$140.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | -$64.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$94.60M derived: sum of 2 quarters · filed 2026-02-06 | -$134.20M derived: sum of 3 quarters · filed 2026-02-06 | -$159.60M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$30.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$69.70M derived: sum of 2 quarters · filed 2025-10-30 | -$95.10M 10-Q · filed 2025-10-30 | -$144.70M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | -$39.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$65.00M 10-Q · filed 2025-07-31 | -$114.60M derived: sum of 3 quarters · filed 2026-02-06 | -$152.70M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | -$25.40M 10-Q · filed 2025-05-01 | -$75.00M derived: sum of 2 quarters · filed 2026-02-06 | -$113.10M derived: sum of 3 quarters · filed 2026-02-06 | -$142.20M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$49.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$87.70M derived: sum of 2 quarters · filed 2026-02-06 | -$116.80M derived: sum of 3 quarters · filed 2026-02-06 | -$148.20M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | -$38.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$67.20M derived: sum of 2 quarters · filed 2024-10-30 | -$98.60M 10-Q · filed 2024-10-30 | -$159.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$29.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$60.50M 10-Q · filed 2024-08-01 | -$120.90M derived: sum of 3 quarters · filed 2025-02-12 | -$156.50M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$31.40M 10-Q · filed 2024-04-24 | -$91.80M derived: sum of 2 quarters · filed 2025-02-12 | -$127.40M derived: sum of 3 quarters · filed 2025-02-12 | -$196.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$60.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$96.00M derived: sum of 2 quarters · filed 2025-02-12 | -$164.90M derived: sum of 3 quarters · filed 2025-02-12 | -$208.20M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$35.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$104.50M derived: sum of 2 quarters · filed 2023-11-08 | -$147.80M 10-Q · filed 2023-11-08 | -$185.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$68.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$112.20M 10-Q · filed 2023-07-25 | -$149.90M derived: sum of 3 quarters · filed 2024-02-14 | -$210.30M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$43.30M 10-Q · filed 2023-04-25 | -$81.00M derived: sum of 2 quarters · filed 2024-02-14 | -$141.40M derived: sum of 3 quarters · filed 2024-02-14 | -$185.70M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$37.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$98.10M derived: sum of 2 quarters · filed 2024-02-14 | -$142.40M derived: sum of 3 quarters · filed 2024-02-14 | -$202.20M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$60.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$104.70M derived: sum of 2 quarters · filed 2022-10-25 | -$164.50M 10-Q · filed 2022-10-25 | -$201.00M 10-Q · filed 2021-10-20 | -$159.00M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2021-06-30 | -$44.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$104.10M 10-Q · filed 2022-07-20 | -$112.40M 10-Q · filed 2021-07-22 | -$98.60M derived: sum of 3 quarters · filed 2023-02-15 | -$125.00M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2021-03-31 | -$59.80M 10-Q · filed 2022-05-03 | -$71.70M 10-Q · filed 2021-04-22 | -$54.30M derived: sum of 2 quarters · filed 2023-02-15 | -$80.70M derived: sum of 3 quarters · filed 2023-02-15 | -$135.50M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2020-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$20.90M derived: sum of 2 quarters · filed 2023-02-15 | -$75.70M derived: sum of 3 quarters · filed 2023-02-15 | -$104.60M 10-K · filed 2023-02-15 | -$131.20M 10-K · filed 2021-02-03 | |||
| 2020-09-30 | -$26.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$81.20M derived: sum of 2 quarters · filed 2021-10-20 | -$110.10M 10-Q · filed 2021-10-20 | -$109.60M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | -$54.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | -$83.70M 10-Q · filed 2021-07-22 | -$85.30M 10-Q · filed 2020-07-22 | -$83.20M derived: sum of 3 quarters · filed 2022-02-03 | -$79.50M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-03-31 | -$28.90M 10-Q · filed 2021-04-22 | -$45.70M 10-Q · filed 2020-04-23 | -$28.40M derived: sum of 2 quarters · filed 2022-02-03 | -$24.70M derived: sum of 3 quarters · filed 2022-02-03 | -$65.10M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $4.20M derived: sum of 2 quarters · filed 2022-02-03 | -$36.20M derived: sum of 3 quarters · filed 2022-02-03 | -$86.90M 10-K · filed 2022-02-03 | -$69.20M 10-K · filed 2020-02-06 | |||
| 2019-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$36.70M derived: sum of 2 quarters · filed 2020-10-21 | -$87.40M 10-Q · filed 2020-10-21 | -$74.40M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$40.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | -$91.10M 10-Q · filed 2020-07-22 | -$78.10M derived: sum of 3 quarters · filed 2021-02-03 | -$101.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$50.70M 10-Q · filed 2020-04-23 | -$37.70M derived: sum of 2 quarters · filed 2021-02-03 | -$61.30M derived: sum of 3 quarters · filed 2021-02-03 | -$74.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$10.60M derived: sum of 2 quarters · filed 2021-02-03 | -$24.00M derived: sum of 3 quarters · filed 2021-02-03 | -$55.70M 10-K · filed 2021-02-03 | $69.10M 10-K · filed 2019-02-06 | |||
| 2018-09-30 | -$23.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$37.00M derived: sum of 2 quarters · filed 2019-10-22 | -$68.70M 10-Q · filed 2019-10-22 | $68.20M 10-Q · filed 2018-10-23 | -$165.10M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-06-30 | -$13.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$45.10M 10-Q · filed 2019-07-24 | -$42.40M 10-Q · filed 2018-07-24 | -$141.50M derived: sum of 3 quarters · filed 2020-02-06 | -$133.70M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-03-31 | -$31.70M 10-Q · filed 2019-04-24 | -$26.10M 10-Q · filed 2018-04-24 | -$128.10M derived: sum of 2 quarters · filed 2020-02-06 | -$120.30M derived: sum of 3 quarters · filed 2020-02-06 | -$175.70M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2017-12-31 | -$96.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$88.60M derived: sum of 2 quarters · filed 2020-02-06 | -$144.00M derived: sum of 3 quarters · filed 2020-02-06 | -$162.10M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$47.60M derived: sum of 2 quarters · filed 2018-10-23 | -$65.70M 10-Q · filed 2018-10-23 | -$126.90M 10-Q · filed 2017-10-24 | -$109.40M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-06-30 | -$55.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$73.50M 10-Q · filed 2018-07-24 | -$117.20M derived: sum of 3 quarters · filed 2019-02-06 | -$133.60M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | -$18.10M 10-Q · filed 2018-04-24 | -$61.80M derived: sum of 2 quarters · filed 2019-02-06 | -$78.20M derived: sum of 3 quarters · filed 2019-02-06 | -$119.00M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$43.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$60.10M derived: sum of 2 quarters · filed 2019-02-06 | -$100.90M derived: sum of 3 quarters · filed 2019-02-06 | -$89.00M 10-K · filed 2019-02-06 | -$91.20M 10-K · filed 2017-02-02 | |||
| 2016-09-30 | -$16.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$57.20M derived: sum of 2 quarters · filed 2017-10-24 | -$45.30M 10-Q · filed 2017-10-24 | -$33.40M 10-Q · filed 2016-10-26 | -$143.60M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-06-30 | -$40.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$28.90M 10-Q · filed 2017-07-25 | -$19.80M 10-Q · filed 2016-07-21 | -$127.20M derived: sum of 3 quarters · filed 2018-02-01 | -$164.60M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-03-31 | $11.90M 10-Q · filed 2017-04-25 | $20.20M 10-Q · filed 2016-04-21 | -$86.40M derived: sum of 2 quarters · filed 2018-02-01 | -$123.80M derived: sum of 3 quarters · filed 2018-02-01 | -$150.90M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2015-12-31 | -$98.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$135.70M derived: sum of 2 quarters · filed 2018-02-01 | -$162.80M derived: sum of 3 quarters · filed 2018-02-01 | -$129.90M 10-K · filed 2018-02-01 | -$82.20M 10-K · filed 2016-02-03 | |||
| 2015-09-30 | -$37.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$64.50M derived: sum of 2 quarters · filed 2016-10-26 | -$31.60M 10-Q · filed 2016-10-26 | -$31.56M 10-Q · filed 2015-10-21 | -$77.01M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | -$27.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $5.80M 10-Q · filed 2016-07-21 | $5.81M 10-Q · filed 2015-07-24 | -$39.61M derived: sum of 3 quarters · filed 2017-02-02 | -$8.11M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $32.90M 10-Q · filed 2016-04-21 | $32.92M 10-Q · filed 2015-04-24 | -$12.51M derived: sum of 2 quarters · filed 2017-02-02 | $18.99M derived: sum of 3 quarters · filed 2017-02-02 | $11.72M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$45.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$13.91M derived: sum of 2 quarters · filed 2017-02-02 | -$21.18M derived: sum of 3 quarters · filed 2017-02-02 | $50.30M 10-K · filed 2017-02-02 | $50.32M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $31.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $24.23M derived: sum of 2 quarters · filed 2015-10-21 | $95.71M 10-Q · filed 2015-10-21 | $86.73M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$7.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $64.21M 10-Q · filed 2015-07-24 | $55.24M derived: sum of 3 quarters · filed 2016-02-03 | $49.32M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $71.48M 10-Q · filed 2015-04-24 | $62.50M derived: sum of 2 quarters · filed 2016-02-03 | $56.58M derived: sum of 3 quarters · filed 2016-02-03 | $65.63M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$14.89M derived: sum of 2 quarters · filed 2016-02-03 | -$5.84M derived: sum of 3 quarters · filed 2016-02-03 | $27.60M 10-K · filed 2016-02-03 | $27.61M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $3.13M derived: sum of 2 quarters · filed 2014-10-22 | $36.58M 10-Q · filed 2014-10-22 | $13.80M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $9.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $42.49M 10-Q · filed 2014-07-23 | $19.72M derived: sum of 3 quarters · filed 2015-02-04 | -$7.40M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $33.44M 10-Q · filed 2014-04-23 | $10.66M derived: sum of 2 quarters · filed 2015-02-04 | -$16.45M derived: sum of 3 quarters · filed 2015-02-04 | -$24.45M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$22.78M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$49.89M derived: sum of 2 quarters · filed 2015-02-04 | -$57.90M derived: sum of 3 quarters · filed 2015-02-04 | -$28.82M 10-K · filed 2015-02-04 | -$31.54M 10-K · filed 2013-02-05 | |||
| 2012-09-30 | -$27.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$35.12M derived: sum of 2 quarters · filed 2013-10-28 | -$6.04M 10-Q · filed 2013-10-28 | -$41.69M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $21.07M 10-Q · filed 2013-07-25 | -$14.58M derived: sum of 3 quarters · filed 2014-02-06 | -$25.87M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $29.07M 10-Q · filed 2013-04-25 | -$6.57M derived: sum of 2 quarters · filed 2014-02-06 | -$17.86M derived: sum of 3 quarters · filed 2014-02-06 | -$10.77M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | -$35.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$46.94M derived: sum of 2 quarters · filed 2014-02-06 | -$39.84M derived: sum of 3 quarters · filed 2014-02-06 | -$20.15M 10-K · filed 2014-02-06 | -$9.23M 10-K · filed 2013-02-05 | |||
| 2011-09-30 | -$11.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | -$4.20M derived: sum of 2 quarters · filed 2012-10-25 | $15.49M 10-Q · filed 2012-10-25 | |||||
| 2011-06-30 | $7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $26.79M 10-Q · filed 2012-07-24 | ||||||
| 2011-03-31 | $19.69M 10-Q · filed 2012-05-01 | |||||||
| 2010-12-31 | -$10.33M 10-K · filed 2013-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |